Register for citation alerts
"Our study showed no physical incompatibility between atosiban and the test drugs in terms of visual changes or nephelometric and pH measurements" Jiménez-Lozano et al (2022).

Example of Y-site drug compatibility

Abstract:

Objective: The physical compatibility of atosiban and selected drugs during simulated Y-site administration was evaluated. We also searched for any compatibility predictions regarding its physicochemical properties.

Study design: Test admixtures were prepared by mixing 5 mL of each study drug solution with 5 mL of atosiban solution in a 1:1 ratio to simulate Y-site infusion. Assessments were made immediately after mixing (baseline), and at 0.5, 1, and 3 h. Visual incompatibility was defined as a presence of haze or any visible particulate matter, gas formation, or colour change. Turbidity and pH variation of the admixtures were also assessed using instrumental methods.

Results: None of the admixtures used with atosiban exhibited visual changes and no incompatibility regarding instrumental methods were observed, because no admixture had an increase of 0.5 nephelometric turbidity units, and no pH change was above one unit when compared to baseline. However, the pH of ampicillin and omeprazole admixtures fell outside of the atosiban stability range.

Conclusions: Our study showed no physical incompatibility between atosiban and the test drugs in terms of visual changes or nephelometric and pH measurements. However, we recommend against atosiban and ampicillin or omeprazole coadministration until complementary compatibility studies are performed.


Reference:

Jiménez-Lozano I, Larrosa-García M, Boix-Montañés A, Bautista SC, Poy MJC. Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs. Eur J Obstet Gynecol Reprod Biol. 2022 Jun 20;275:106-109. doi: 10.1016/j.ejogrb.2022.06.006. Epub ahead of print. PMID: 35779331.